Literature DB >> 7557078

Turnover of the gastric H+,K(+)-adenosine triphosphatase alpha subunit and its effect on inhibition of rat gastric acid secretion.

K Gedda1, D Scott, M Besancon, P Lorentzon, G Sachs.   

Abstract

BACKGROUND & AIMS: The rate of turnover and the effect of inhibition of acid secretion on the turnover of gastric H+,K(+)-adenosine triphosphatase (ATPase) is unknown. The aim of this study was to determine the turnover of the alpha subunit of gastric H+,K(+)-ATPase in rats under control conditions and during inhibition of acid secretion by ranitidine or omeprazole.
METHODS: The turnover of the alpha subunit of the ATPase was determined by measuring the loss of incorporated 35S-methionine. This was compared with the rate of recovery of K(+)-stimulated ATPase activity in the omeprazole-treated animals.
RESULTS: The half-life of the alpha subunit was 54 hours. A 1-week treatment with omeprazole had no significant effect, but the half-life increased to 125 hours (P < 0.01) after continuous ranitidine infusion. After omeprazole treatment, K(+)-stimulated ATPase activity recovered with a half-time of 15 hours.
CONCLUSIONS: The turnover of the gastric ATPase subunit was independent of omeprazole inhibition but was prolonged by ranitidine. The effect of ranitidine suggests that the resting pump in tubulovesicles may turn over more slowly than the stimulated pump in the secretory canaliculus. The rapid recovery of ATPase activity compared with turnover after omeprazole is caused by both H+,K(+)-ATPase synthesis and loss of covalently bound drug.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7557078     DOI: 10.1016/0016-5085(95)90571-5

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  22 in total

Review 1.  Update on the mechanisms of gastric acid secretion.

Authors:  Sascha Kopic; John P Geibel
Journal:  Curr Gastroenterol Rep       Date:  2010-12

Review 2.  Gastric H,K-ATPase as a drug target.

Authors:  Jai Moo Shin; George Sachs
Journal:  Dig Dis Sci       Date:  2006-04-28       Impact factor: 3.199

Review 3.  Molecular mechanisms in therapy of acid-related diseases.

Authors:  J M Shin; O Vagin; K Munson; M Kidd; I M Modlin; G Sachs
Journal:  Cell Mol Life Sci       Date:  2008-01       Impact factor: 9.261

4.  Helicobacter pylori-induced posttranscriptional regulation of H-K-ATPase α-subunit gene expression by miRNA.

Authors:  Yong-Mei Zhang; Jennifer M Noto; Charles E Hammond; Jeremy L Barth; W Scott Argraves; Steffen Backert; Richard M Peek; Adam J Smolka
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-02-06       Impact factor: 4.052

5.  Up-regulation of H2 receptor and adenylate cyclase in rabbit parietal cells during prolonged treatment with H2-receptor antagonists.

Authors:  K Takeuchi; M Kajimura; M Kodaira; S Lin; H Hanai; E Kaneko
Journal:  Dig Dis Sci       Date:  1999-08       Impact factor: 3.199

6.  The binding selectivity of vonoprazan (TAK-438) to the gastric H+, K+ -ATPase.

Authors:  D R Scott; K B Munson; E A Marcus; N W G Lambrecht; G Sachs
Journal:  Aliment Pharmacol Ther       Date:  2015-09-30       Impact factor: 8.171

7.  Helicobacter pylori represses proton pump expression and inhibits acid secretion in human gastric mucosa.

Authors:  Arindam Saha; Charles E Hammond; Craig Beeson; Richard M Peek; Adam J Smolka
Journal:  Gut       Date:  2010-07       Impact factor: 23.059

Review 8.  The gastric HK-ATPase: structure, function, and inhibition.

Authors:  Jai Moo Shin; Keith Munson; Olga Vagin; George Sachs
Journal:  Pflugers Arch       Date:  2008-06-06       Impact factor: 3.657

Review 9.  Treatment of acid-related diseases in the elderly with emphasis on the use of proton pump inhibitors.

Authors:  Bjarni Thjodleifsson
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

10.  1-Arylsulfonyl-2-(pyridylmethylsulfinyl) benzimidazoles as new proton pump inhibitor prodrugs.

Authors:  Jai Moo Shin; George Sachs; Young-moon Cho; Michael Garst
Journal:  Molecules       Date:  2009-12-15       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.